Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)
      QxMD      Google Scholar   
Citation:
Cancer vol 120 (22) 3575-3583
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
Received
Note:
971 is parent abstract
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
4
Parents:
958   971  
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA035267, CA33601, U10 CA037417, N01 CA035431, U10 CA035269, CA-37404, U10 CA031946, U10 CA033601, CA-35195, U10 CA037404, N01 CA035119, U10 CA063848, U10 CA035195, CA-35103, CA-25224, U10 CA035272, CA-35113, U10 CA035101, UG1 CA189823, U10 CA035113, P30 CA015083, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, U10 CA035119, CA-37417, CA-35272, CA-35269, CA-35101, U10 CA025224, CA31946, CA-35267, CA-63849, U10 CA035103  
Corr. Author:
 
Authors:
                         
Primary Study
N08C3
Secondary Studies:
Phases:
3
Keywords:
gabapentin, delayed nausea, delayed vomiting, antiemetic therapy, randomized controlled trial